Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease

    Research output: Contribution to journalArticlepeer-review


    A common feature of Alzheimer's disease (AD) is weight loss, even though there is often an increase in food intake in AD patients. The reasons for this weight loss are unknown, but may be due to increased energy expenditure (metabolic rate) or a reduction in energy intake. This was investigated in the present study, using a triple-transgenic (3xTgAD) mouse model of AD. Two-month-old 3xTgAD mice displayed greater food intake (17%) and body weight (34%) but no difference in metabolic rate, as compared with nontransgenic controls (non-Tg). At 12 months of age, 3xTgAD mice still consumed more food (30%), but their body weight was significantly lower (15%) than non-Tg controls. This reduction in body weight was accompanied by a significant rise in metabolic rate, indicated by greater oxygen consumption (24%) and carbon dioxide production (29%); the effects were also observed in 18-month-old 3xTgAD mice. These data demonstrate for the first time the existence of a hypermetabolic state in an experimental model of AD, but whether this can explain the weight loss observed in AD patients remains to be determined. © 2012 Elsevier Inc.
    Original languageEnglish
    Pages (from-to)187-193
    Number of pages6
    JournalNeurobiology of Aging
    Issue number1
    Publication statusPublished - Jan 2012


    • 3xTgAD
    • Alzheimer's disease
    • Body weight
    • Energy balance
    • Energy expenditure
    • Food intake
    • Hypermetabolism

    Research Beacons, Institutes and Platforms

    • Dementia@Manchester


    Dive into the research topics of 'Hypermetabolism in a triple-transgenic mouse model of Alzheimer's disease'. Together they form a unique fingerprint.

    Cite this